| Title | Author(s) | Issue date | ???itemlist.??? |
| Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease | Maraganore, D. M.; de Andrade, M.; Elbaz, A.; Farrer, M. J.; Ioannidis, J. P.; Kruger, R.; Rocca, W. A.; Schneider, N. K.; Lesnick, T. G.; Lincoln, S. J.; Hulihan, M. M.; Aasly, J. O.; Ashizawa, T.; Chartier-Harlin, M. C.; Checkoway, H.; Ferrarese, C.; Hadjigeorgiou, G.; Hattori, N.; Kawakami, H.; Lambert, J. C.; Lynch, T.; Mellick, G. D.; Papapetropoulos, S.; Parsian, A.; Quattrone, A.; Riess, O.; Tan, E. K.; Van Broeckhoven, C. | 24-Nov-2015 | - |
| Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas | Trizna, Z.; de Andrade, M.; Kyritsis, A. P.; Briggs, K.; Levin, V. A.; Bruner, J. M.; Wei, Q.; Bondy, M. L. | 24-Nov-2015 | - |
| Increased chromosomal instability in peripheral lymphocytes and risk of human gliomas | El-Zein, R.; Bondy, M. L.; Wang, L. E.; de Andrade, M.; Sigurdson, A. J.; Bruner, J. M.; Kyritsis, A. P.; Levin, V. A.; Wei, Q. | 24-Nov-2015 | - |
| Mutagen sensitivity and risk of gliomas: a case-control analysis | Bondy, M. L.; Kyritsis, A. P.; Gu, J.; de Andrade, M.; Cunningham, J.; Levin, V. A.; Bruner, J. M.; Wei, Q. | 24-Nov-2015 | - |
| Risk assessment for developing gliomas: a comparison of two cytogenetic approaches | El-Zein, R.; Bondy, M. L.; Wang, L. E.; de Andrade, M.; Sigurdson, A. J.; Bruner, J. M.; Kyritsis, A. P.; Levin, V. A.; Wei, Q. | 24-Nov-2015 | - |
| UCHL1 is a Parkinson's disease susceptibility gene | Maraganore, D. M.; Lesnick, T. G.; Elbaz, A.; Chartier-Harlin, M. C.; Gasser, T.; Kruger, R.; Hattori, N.; Mellick, G. D.; Quattrone, A.; Satoh, J.; Toda, T.; Wang, J.; Ioannidis, J. P.; de Andrade, M.; Rocca, W. A. | 24-Nov-2015 | - |
